首页|期刊导航|疑难病杂志|缺血性脑卒中患者血清CGN、FNDC5、PAR4水平与病情及并发血管性认知功能障碍的相关性

缺血性脑卒中患者血清CGN、FNDC5、PAR4水平与病情及并发血管性认知功能障碍的相关性OA

The correlation between serum CGN,FNDC5 and PAR4 levels and the condition,concurrent vascular cognitive im-pairment in patients with ischemic stroke

中文摘要英文摘要

目的 分析缺血性脑卒中(IS)患者血清扣带蛋白(CGN)、Ⅲ型纤维连接蛋白域蛋白5(FNDC5)、血小板活化蛋白酶激活受体4(PAR4)水平与病情及并发血管性认知功能障碍(VCI)的相关性.方法 选取2023年7月—2025年7月延安大学附属医院神经内科收治的IS患者103例作为IS组,根据病情程度将IS患者分为轻度(n=26)、中度(n=35)、中重度(n=22)、重度(n=20),根据VCI发生情况分为VCI亚组(n=32)和NVCI亚组(n=71),另招募同期医院健康体检者105例作为健康对照组(CON组).采用ELISA法检测血清CGN、FNDC5、PAR4水平;相对危险度分析不同血清CGN、FNDC5、PAR4水平对IS患者并发VCI的影响;受试者工作特征(ROC)曲线分析血清sCGN、FNDC5、PAR4水平对IS患者并发VCI的预测价值.结果 IS组患者血清CGN、PAR4水平高于CON组,FNDC5 水平低于 CON 组(t/P=50.227/<0.001、24.772/<0.001、40.118/<0.001);轻度、中度、中重度、重度患者血清CGN、PAR4 水平依次升高,FNDC5 水平依次降低(F/P=165.761/<0.001、179.691/<0.001、166.107/<0.001);VCI 亚组患者血清CGN、PAR4水平高于NVCI亚组,血清FNDC5水平低于NVCI亚组(t/P=7.180/<0.001、7.303/<0.001、7.193/<0.001);血清CGN高水平、FNDC5高水平、PAR4高水平IS患者发生VCI的风险分别是血清CGN低水平、FNDC5 低水平、PAR4 低水平 IS 患者的 1.947 倍、0.463 倍、2.506 倍(x2/P=4.820/0.028、6.195/0.013、8.496/0.004);血清CGN、FNDC5、PAR4水平及三者联合预测IS患者并发VCI的曲线下面积(AUC)分别为0.848、0.850、0.856、0.921,三者联合预测的AUC大于各指标单独预测(Z/P=2.264/0.024、2.763/0.010、2.521/0.015).结论 IS患者血清CGN、PAR4水平升高,FNDC5水平降低,均与病情程度相关,且对IS并发VCI有一定的预测价值.

Objective The correlation between the levels of serum corticotropin-releasing factor(CGN),type Ⅲ fi-bronectin domain protein 5(FNDC5),and platelet-activating protease-activating receptor 4(PAR4)in patients with ischemic stroke(IS)and their disease condition as well as the concurrent vascular cognitive dysfunction(VCI)was analyzed.Methods One hundred and three patients with IS admitted to the Neurology Department of Yan'an University Affiliated Hospital from July 2023 to July 2025 were selected as the IS group.They were divided into mild(n=26),moderate(n=35),moderately severe(n=22),and severe(n=20)based on the severity of the disease,and were further divided into the VCI subgroup(n=32)and the non-VCI subgroup(n=71)according to the occurrence of VCI.105 healthy individuals who underwent physical examinations at the same hospital during the same period were recruited as the CT group.ELISA was used to detect the levels of serum CGN,FNDC5,and PAR4;relative risk analysis was conducted to identify the factors influencing the concurrent VCI in IS patients;ROC analysis was performed to evaluate the predictive value of serum sCGN,FNDC5,and PAR4 for VCI.Re-sults The results showed that the serum levels of CGN and PAR4 in the IS group were higher than those in the CT group,while the serum level of FNDC5 was lower than that in the CT group(t/P=50.227/<0.001,24.772/<0.001,40.118/<0.001);the serum levels of CGN and PAR4 increased successively in patients with mild,moderate,moderate-severe,and severe condi-tions,while the serum level of FNDC5 decreased successively(F/P=165.761/<0.001,179.691/<0.001,166.107/<0.001);com-pared with the NVCI sub-group,the serum levels of CGN,PAR4,and FNDC5 in the VCI sub-group were higher than those in the NVCI sub-group,while the serum level of FNDC5 was lower(t/P=7.180/<0.001,7.303/<0.001,7.193/<0.001);patients with high serum levels of CGN,FNDC5,and PAR4 had a 1.947-fold,0.463-fold,and 2.506-fold higher risk of developing VCI compared to those with low serum levels of CGN,FNDC5,and PAR4;the AUCs of serum CGN,FNDC5,PAR4,and their combination for predicting VCI in IS patients were 0.848,0.850,0.856,and 0.921,respectively,and the AUC of the com-bination of the three was larger(Z/P=2.264/0.024,2.763/0.010,2.521/0.015).Conclusion The levels of serum CGN and PAR4 increase and the level of FNDC5 decreases in patients with IS.All are related to the severity of the disease and have certain predictive value for IS complicated with VCI.

郭改艳;刘静;师强;贾蕾

716000 陕西延安,延安大学附属医院东关心脑血管病医院神经内科716000 陕西延安,延安大学附属医院东关心脑血管病医院神经内科716000 陕西延安,延安大学附属医院东关心脑血管病医院神经内科716000 陕西延安,延安大学附属医院东关心脑血管病医院神经内科

医药卫生

缺血性脑卒中血管性认知功能障碍扣带蛋白Ⅲ型纤维连接蛋白域蛋白5血小板活化蛋白酶激活受体相关性

Ischemic strokeVascular cognitive impairmentCingulinFibronectin type Ⅲ domain-containing protein 5Protease activated receptor 4Correlation

《疑难病杂志》 2026 (5)

547-551,5

陕西省卫生健康科研基金项目(2022D022) Shaanxi Provincial Health and Wellness Research Fund Project(2022D022)

10.3969/j.issn.1671-6450.2026.05.007

评论